Evidence map›Paper›PMID 29503208›Full record

ArticleCell chemical biology2018

Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery.

Jaak Simm, Günter Klambauer, Adam Arany, Marvin Steijaert, Jörg Kurt Wegner, Emmanuel Gustin, Vladimir Chupakhin, Yolanda T Chong, Jorge Vialard, Peter Buijnsters and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell chemical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 1 pooled it
31.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 1 synthesis or guideline pooled it, 248 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Single-cell hit calling in high-content imaging screens with Buscar.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Jaak SimmESAT-STADIUS, KU Leuven, Kasteelpark Arenberg 10, 3001 Leuven, Belgium.
Günter KlambauerInstitute of Bioinformatics, Johannes Kepler University Linz, Altenbergerstrasse 69, 4040 Linz, Austria.
Adam AranyESAT-STADIUS, KU Leuven, Kasteelpark Arenberg 10, 3001 Leuven, Belgium.
Marvin SteijaertOpen Analytics NV, Jupiterstraat 20, 2600 Antwerp, Belgium.
Jörg Kurt WegnerJanssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
Emmanuel GustinJanssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
Vladimir ChupakhinJanssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
Yolanda T ChongJanssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
Jorge VialardJanssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
Peter BuijnstersJanssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
Ingrid VelterJanssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
Alexander VapirevFacilities for Research, KU Leuven, Willem de Croylaan 52c, Box 5580, 3001 Leuven, Belgium.
Shantanu SinghImaging Platform, Broad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA 02142, USA.
Anne E CarpenterImaging Platform, Broad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA 02142, USA.
Roel WuytsExaScience Life Lab, IMEC, Kapeldreef 75, 3001 Leuven, Belgium.
Sepp HochreiterInstitute of Bioinformatics, Johannes Kepler University Linz, Altenbergerstrasse 69, 4040 Linz, Austria.
Yves MoreauESAT-STADIUS, KU Leuven, Kasteelpark Arenberg 10, 3001 Leuven, Belgium.
Hugo CeulemansJanssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium. Electronic address: hceulema@its.jnj.com.
Janssen (Belgium) · BEKU Leuven · BEBroad Institute · USJohannes Kepler University of Linz · ATIMEC · BE

Funding

Extracting rich information from biological imagesR35GM122547 · NIGMS · BROAD INSTITUTE, INC. · PI Anne E. Carpenter · 2017 to 2026
$6.2M
NIGMS NIH HHS R35 GM122547
6 · The paper itself

Abstract

In both academia and the pharmaceutical industry, large-scale assays for drug discovery are expensive and often impractical, particularly for the increasingly important physiologically relevant model systems that require primary cells, organoids, whole organisms, or expensive or rare reagents. We hypothesized that data from a single high-throughput imaging assay can be repurposed to predict the biological activity of compounds in other assays, even those targeting alternate pathways or biological processes. Indeed, quantitative information extracted from a three-channel microscopy-based screen for glucocorticoid receptor translocation was able to predict assay-specific biological activity in two ongoing drug discovery projects. In these projects, repurposing increased hit rates by 50- to 250-fold over that of the initial project assays while increasing the chemical structure diversity of the hits. Our results suggest that data from high-content screens are a rich source of information that can be used to predict and replace customized biological assays.

Indexed as

Machine LearningNeural Networks, ComputerAntineoplastic AgentsCell Line, TumorDrug RepositioningHigh-Throughput Screening AssaysHumansImage Processing, Computer-AssistedNeoplasmsAntineoplastic AgentsBayesian matrix factorizationcomputational chemistrydeep learningdrug discoveryhigh-content imaginghigh-throughput screeningmachine learningmatrix factorization

Identifiers

PMID29503208
PMCPMC6031326
OpenAlexW2794301983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.